Multiple Myeloma
VRd induction, autologous HSCT, and BCMA CAR-T (domestic cilta-cel/equecabtagene) for relapsed disease.
Treatment Plans for Multiple Myeloma
Compare evidence-based options at top Chinese hospitals — transparent pricing, typical wait, and recovery time.
BCMA CAR-T Cell Therapy
Autologous BCMA-directed CAR-T for relapsed/refractory MM.
Prices are indicative ranges in USD based on partner hospital published rates. Final quote depends on your medical records and selected hospital — request a free personalized estimate.
Why China for Multiple Myeloma
Domestic BCMA CAR-T at 1/3 US price; experienced auto-HSCT programs.
Recommended Hospitals for Multiple Myeloma
Hand-picked by case volume, outcomes, and international patient experience.
Ruijin Hospital, Shanghai Jiao Tong University
Peking Union Medical College Hospital
Peking University Cancer Hospital
Sun Yat-Sen University Cancer Center
Shanghai Cancer Center, Fudan University
Tianjin Medical University Cancer Hospital
Sichuan Cancer Hospital and Institute
About Multiple Myeloma
- Bone pain
- Anemia
- Recurrent infections
- Renal failure
- Hypercalcemia
- Plasma cell dyscrasia
- MGUS progression
- Genetic
- SPEP/UPEP
- Bone marrow biopsy
- FISH cytogenetics
- PET-CT
- MRD assessment
Evidence & Reference Standards
Our oncology pathways align with internationally recognized cancer-care guidelines:
SSAnkang Health is a medical-tourism coordination service; clinical procedures are performed by JCI-accredited Chinese hospitals. This page is for general information and does not constitute medical advice.